Autopsy report · NCT03594955
First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 4 months before it started.
- Ran for about 2 years 3 months before it stopped.
- 7 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Leukaemia
- Interventions
- SAR440234
- Participants
- 7
- Sites
- 4
- Countries
- France, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.